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Microbes, Men, and Animals 
Dr. Charle11 Beruon (left) and Dr. Jon Palmer. 
Unlike gregarious human beings, animals do 
not hold conventions, and are therefore spared 
the discomfort� and death, visited upon some 
of the people who convened in Philadelphia in 
1976. As you probably recall, this was the 
infamous American Legion convention held at 
the stately Bellevue Stratford hotel and the 
disease outbreak brought about the demise of 
a Philadelphla landmark. Naturally, the mal· 
ady was quickly JabeUed "Legionaires Disease." 
Subsequently, there have been some well pub· 
licized outbreaks of this disease in other parts 
of the world, and the causative organism has 
been identified as Legion.ella pneumophilia. 
It now appears that animals may be carri· 
era of this organism, and Dr. Charles E. Ben· 
son has begun a screening study to determine 
whether this is true. Dr. Benson is associate 
professor ot microbiology in the School of 
Veterinary Medicine, whose laboratory is 
located at New Bolton Center. Dr. Benson has 
been involved in some basic studies on the 
cbarac"teristics of L. pneumophilia which is an 
organism that invades body cells. L. pneltl1W­
philia itselr has never been isolated from 
animals. but. antibodies, produced in response 
to the organism, have been detected. Dr. Ben­
son•s work is concerned with direct isolation of 
the bacterium, a difficult chore. The organism 
can be isolated from human beings where it 
causes an atypical pneumonia, and Dr. Benson 
has it growing in cell culture in his laboratory. 
Dr. Benson's quest for this organism in animals 
is iUustrative of one of his basic philosophies, 
to wit, "we only find what we look for." Des· 
pite some great strides, Dr. Benson points out 
that we are still on the frontier in our efforts 
to specifically identify bacteria that cause 
many iniectious diseases in animals. There are 
a number of clinical syndromes in animals "that 
appear to be of an infectious nature, but for 
which a causative organism has not been iden· 
tilled. With this in mind, Dr. Benson and var­
ious clinicians at New Bohon Center have 
teamed together in the hope of gaining a bet· 
ter understanding of the pathogenesis of cer· 
tain of these perplexing syndromes. The clini­
cians with whom he has been working most 
closely are Dr. Robert Whitlock, Dr. Robert 
Dyer, and Dr. Jon Palmer. Prior to Dr. Ben· 
son's arrival at New Bolton Center in January 
1961, this sort of cooperative effort in the 
study of infectious diseases had been ne· 
glected. Dr. Whitlock, who is associate 
professor of medicine and chief of medical 
services at New Bolton Center is quite enthu­
siastic about the future of this field. 
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Another major research interest of Dr. Ben· 
son is the study of the organism, Salmonella. 
This is a pathogen t.hat has long been the 
plague of animals and humans. Interestingly, it 
was first discovered by a veterinarian, Dr. 
DarueJ E. Salmon, who was the first Chief of 
the Federal Bureau of Animal Industry. One 
problem in any study of Salmonella is that 
there are over 1,200 strains of t.he organism. 
WhiJe certain strains have been identified as 
the cause of the disease in animals known as 
salmone1Josis, it is possible that other, uniderr 
tified strains may also be involved. One of the 
objects of Dr. Ben11on's work will be to attempt 
to define mechanisms of pathogenesis. The 
particular strain now most commonly asso­
ciated with colitis in horses is Salmonella 
typhimurium. The common clinical signs are 
hyperthennia, diarrhea, co.bcy pain, and occa­
sionally a rapidly developing septicemia. One 
characteristic of equine salmonellosis is that it 
strikes horses that are in stressful situations, 
includjng transport, weaning, worming, or any 
other situation that lowers resistance. Surgery 
may predispose horses to salmonellosis, and 
one aspect of the work of Dra. Benson and 
Palmer is to examine horses post-surgically for 
the presence of Salmonella. Salmonellosis is 
highly contagious at the local level; it can 
become entrenc.�hed on a particular farm. 
Horses with salmonellosis at New Bolton Cen· 
ter are placed in isolation. 
Dr. Benson states that some SalmoneUa 
strains have the capability of producing to.x.im. 
This is related to the genetic make-up of a 
particular organism. Honles with toxemia. 
associated with salmonellosis, have been 
observed at New &Lton Center, and the se.a.r.:h 
£or strains that produce this phenomena will 
be part of the Benson/Palmer study. 
In the past ten years there has been an 
increase in the incidence of Salmonella infec· 
tions in both humans and animals. Recently 
there have been outbreaks of the disease in 
humans foJJowing t.he consumption of cooked 
beef. One problem in the spread of salmonel­
losis is the fact that most species, including 
humans, can act tLs carriers of the bacteria 
without exhibiting overt clinical signs. It is 
estimated that at least ten percent of the horse 
population are carriers of Salmonella. 
Diagnosis of salmonellosis is based upon 
identification of or�anisms in fecal culture. 
This may he difficult in carrier animals, and 
Dr. Beru;on hopes to improve diagnostic 
methods. 
A cooperative study in which Dr. Benson is 
involved witb Dr. Dyer, concerns the etiology 
of "shipping fever,. in cattle and horses. Dr. 
Benson is also conducting basic research on 
metaboli� pathways in Salmonella and other 
organisms. While he is relatively new to the 
faculty of the School of Veterinary Medicine, 
Dr. Benson has been at the University of Penn· 
sylvania since 1975, with the School of Allied 
Medical Professions. In addition to research he 
teaches in the core and elective portions of the 
veterinary curriculum, and is administrator of 
the clinical laboratory at New Bolton Center. 
Canine 
Epilepsy 
Epilepsy is one of the most common canine 
neurological complaints, yet control of sei­
zures in dogs remains a difficult, frustrating, 
and often unrewarding task for veterinarian, 
owner, and patient. In an effort to remedy 
this situation. t••e Vetednary Hospital of the 
University of Pennsylvania has recently insti· 
tuted an epilepsy foundation for dogs called 
the Canine Epilepsy Service under the direc· 
torship of Or. George C. Farnbach, V.M.D., 
Ph.D., assi�tant professor of neurology. This 
canine epilepsy center has the ambitious 
goals of improving the control of seizures iu 
epileptic dogs and, if possible, eliminating 
seizures altogether through a cooperative 
effort involving pets, their owners, their 
locaJ veterinarians. and the facilities of the 
Canine Epilepsy Service (CES). 
Dogs, like people, suffer from epilepsy of 
varying inten5ities and types. Like the physi­
cian, a veterinarian is generally forced to 
attempt to control epilepsy through the use 
of anticonvulsant drugs. The control of seiz­
ures in humans is tnore often successful than 
it is in dogs because considerably more 
information about the use and effectiveness 
of anticonvulsant drugs in humans is avail­
able to the physician. The process of control­
ling human �:�ei.zures has been considerably 
advanced by the study of large numbers of 
epileptic patients on a variety of treatment 
regimens, which was made possible by cen· 
tralized epilepsy study groups. These groups 
have deveJoped a wealth of knowledge about 
the efficacy of $pecHic drugs, the blood levels 
required to control seizures. and the toxic 
and long-term effects of these drugs. Modern 
technology now permi1s relatively inexpen­
sive monitoring of serum drug leve]s, ena· 
bling the physician to adjust or switch anti· 
convulsants for maximum effect and 
minimum toxicity baAed on the knowledge of 
each drug and the individual patient's blood 
levels. No such body of knowledge exists in 
veterinary medicine, leaving the practitioner 
to determine the appropriate anticonvulsant 
for the patient on a limited and basically 
blind triaJ-and-error basis. This can be a 
costly and frustrating process. 
"There are a variety of drugs and drug 
combinations which can be used in control 
protocols, yet accurate information about the 
effecti\•e and toxic blood levels of these 
drugs or about their long-term side effects in 
the dog does not exist, .. Farnbach explained. 
�At the CES we hope to collect this kind of 
information over u Lon� period of time. Our 
goal is to monitor at least 1,000 dogs for at 
least three yearM." 
To illustrate the importance of drug 
information, F'arnbach cited Dilantin, a drug 
commonly used in both humans and dogs to 
control seizures. uln humans, DiJantin is 
effective in many patients, but to control 
seizures, blood levels above 10 ug/ml are 
required. An effective dose for an adult 
human is about 300 mg/day. We do not know 
